Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Beluga Health vs NuviaRx

Beluga Health
Graded #430

Lower grade

vs+17.700000000000003
NuviaRx
Graded #69

Higher grade

The verdict

NuviaRx takes it — 73.5/100 to 55.8/100.

NuviaRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NuviaRx is a GLP-1 weight-loss telehealth service offering compounded semaglutide (from $140/mo) and tirzepatide (from $170/mo) with transparent pricing and free delivery.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNuviaRx +42
45
87
Dose & formulationNuviaRx +32
40
72
Clinical oversightNuviaRx +6
76
82
Labs & monitoringBeluga Health +9
62
53
FulfillmentNuviaRx +8
64
72
Contract termsEven
55
55
Beluga Health · left barNuviaRx · right bar

The numbers

MetricBeluga HealthNuviaRx
WeighScore55.8/10073.5/100
GradeCC
Scorecard rank#430#69
SemaglutideNot disclosed$140/mo (all doses, compounded)
TirzepatideNot disclosed$170/mo (all doses, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Beluga Health

Graded #430 · C

Strengths

  • Supports GLP-1 care with compounded semaglutide and tirzepatide
  • Board-certified providers and a 50-state medical infrastructure
  • LegitScript certified with SOC 2 and ISO 27001 security
  • Pharmacies follow FDA/USP standards with third-party batch testing
  • Powers many DTC brands as a turnkey telehealth backbone

Where it loses points

  • White-label B2B group, not a direct consumer-facing service
  • Offers compounded, not FDA-approved branded, GLP-1s
  • No public consumer pricing for the GLP-1 offering
  • Cited among nationwide groups tied to FDA telehealth GLP-1 scrutiny
  • Care quality varies by the consumer brand using the platform
NuviaRx

Graded #69 · C

Strengths

  • Transparent, affordable pricing — compounded semaglutide from $140/mo, tirzepatide from $170/mo
  • Free delivery included; clinical evaluation and prescription bundled (if eligible)
  • Full legal suite published (Terms, Privacy, HIPAA Notice, Informed Consent, Medical Disclaimer)
  • Named operating entity (NuviaRx Health Inc.) with a US address and phone support

Where it loses points

  • Compounding pharmacy partner not named ('partner pharmacy')
  • Not LegitScript-certified (no certification displayed)
  • Lowest pricing is 'as low as' — likely requires a longer prepaid plan
  • State availability not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard